On August 1, 2017, the Department of Cancer Research and Molecular Medicine (IKMM) and the Department of Laboratory Medicine, Children's and Women's Health (LBK) merged into the Department of Clinical and Molecular Medicine. We are currently updating the websites.
Research at the Department
The department has a broad range of research activities. Broadly, these include basic, clinical and palliative cancer research, immunology and mechanisms of infection, population-based studies of human disease, as well as research within some aspects of internal medicine.
The close cooperation between Trondheim University Hospital and the basic research groups greatly facilitate translational research, a major priority in the department.
Departmental research units
The research groups are organized under five different departmental research units:
Unit for Molecular Biology conducts research within genome stability & DNA repair, lung cancer, bioinformatics, as well as experimental gastrosurgery and physiology. The research employs a wide range of technologies, including animal models (e.g. transgenic mice), biobanks, high throughput genetic analysis, proteomics and other functional genomics methods.
Unit for Cell Biology conducts research within molecular innate immunology, e.g. Toll-receptors and cytokines in inflammation, infection and cancer, as well as haematological malignancies, and reproductive biology (particularly preeclampsia).
Unit for Cancer and Clinical Research conducts extensive research on palliative care in cancer, treatment of lung cancer and other forms of cancer, such as prostate cancer. Research in dermatology is carried out in collaboration with Unit for Cell Biology.
Unit for Gastroenterology conducts research on gastrophysiology and gastroenterology, such as inflammatory disease and gastric cancer. The unit also takes advantage of high throughput methods for gene expression studies offered by NMC (Norwegian Microarray Consortium) headed by the unit manager.
Centre of Molecular Inflammation Research (CEMIR) aims towards identifying new therapeutic targets and developing new tools for diagnosing inflammatory diseases.